Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2012
03/08/2012US20120059151 Non-Functional P2X7 Receptor
03/08/2012US20120058538 Helper-free Rescue of Recombinant Negative Strand RNA Virus Systems
03/08/2012US20120058487 Compositions and methods for detecting klebsiella pneumoniae
03/08/2012US20120058190 Food containing prolactin
03/08/2012US20120058187 Water-in-oil type emulsion for treating a disease of the eye
03/08/2012US20120058162 Stable, spray dryed, immunogenic, viral compositions
03/08/2012US20120058154 Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus m2e
03/08/2012US20120058153 Synthetic nanocarrier vaccines comprising proteins obtained or derived from human influenza a virus hemagglutinin
03/08/2012US20120058148 Certain aminoalkyl glucosaminide phosphate compounds and their use
03/08/2012US20120058147 Geographically Region Specific Allergy Immunotherapy for Companion Animals
03/08/2012US20120058146 Immunogens from uropathogenic escherichia coli
03/08/2012US20120058145 Method for producing virus from cell culture involving homogenization
03/08/2012US20120058144 Lipids and compositions for the delivery of therapeutics
03/08/2012US20120058143 Staphylococcus aureus proteins and nucleic acids
03/08/2012US20120058142 Vaccine for protection against shigella sonnei disease
03/08/2012US20120058141 Chimeric newcastle disease viruses and uses thereof
03/08/2012US20120058139 Novel multimodular assembly useful for intracellular delivery
03/08/2012US20120058138 Novel Adenovirus Vectors
03/08/2012US20120058137 Efficient transport into white blood cells
03/08/2012US20120058136 NON-SPLICING VARIANTS OF gp350/220
03/08/2012US20120058135 Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
03/08/2012US20120058134 Method for fermentation and cultivation, fermented plant extract, fermented plant extract powder, and composition containing the extract of fermented plant
03/08/2012US20120058132 Treatment of glycogen storage disease type II
03/08/2012US20120058131 Pta089 protein
03/08/2012US20120058130 Compositions and methods for diagnosing, treating, and preventing prostate conditions
03/08/2012US20120058128 Anti- integrin antibodies, compositions, methods and uses
03/08/2012US20120058127 PAR2 Agonists for Use in the Treatment or Prevention of Influenza Virus Type A Infections
03/08/2012US20120058126 Anti-vegfr-3 antibody compositions
03/08/2012US20120058125 Methods relating to peripheral administration of nogo receptor polypeptides
03/08/2012US20120058124 Influenza virus-neutralizing antibody and screening method therefor
03/08/2012US20120058123 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
03/08/2012US20120058122 Antibodies Directed to HER-3 and Uses Thereof
03/08/2012US20120058121 Methods and compositions for treating lupus
03/08/2012US20120058120 Targets for Growth Factor Signalling and Methods of Therapy
03/08/2012US20120058119 Human tumor necrosis factor tr21 and methods based thereon
03/08/2012US20120058118 A-beta binding polypeptides
03/08/2012US20120058117 Neuropilin-1 inhibitors
03/08/2012US20120058116 Fgfr1c antibody combinations
03/08/2012US20120058115 method for promoting bone growth using activin-actriia antagonists
03/08/2012US20120058114 ERBB2 antibodies comprising modular recognition domains
03/08/2012US20120058113 Cancer treatment method
03/08/2012US20120058112 Antibodies
03/08/2012US20120058111 Sialylated antigen-specific antibodies for treatment or prophylaxis of unwanted inflammatory immune reactions and methods of producing them
03/08/2012US20120058110 Method for Predicting the Responsiveness to an Anti-TNF Alpha Antibody Treatment
03/08/2012US20120058109 Reelin rescues cognitive function
03/08/2012US20120058108 Methods and uses involving genetic aberrations of nav3 and aberrant expression of multiple genes
03/08/2012US20120058107 Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors
03/08/2012US20120058106 Novel cancer-associated antigen
03/08/2012US20120058105 Method of treatment of vascular complications
03/08/2012US20120058083 Therapies for Chronic Inflammatory Demyelinating Polyneuropathy Using Interferon-Beta
03/08/2012US20120058082 Methods and compositions for treatment
03/08/2012US20120058079 1,2,5-Oxadiazoles as Inhibitors of Indoleamine 2,3-Dioxygenase
03/08/2012US20120058051 Anti-human ror1 antibodies
03/08/2012US20120058048 Directed radiotherapy
03/08/2012CA2810217A1 Anti-cxcl13 antibodies and methods of using the same
03/08/2012CA2810171A1 Antibodies that bind to adrenomedullin and to adrenomedullin receptors and the uses thereof as drugs
03/08/2012CA2810016A1 Novel modulators and methods of use
03/08/2012CA2810011A1 Adsorption of immunopotentiators to insoluble metal salts
03/08/2012CA2809890A1 Peptide containing multiple n-linked glycosylation sequons
03/08/2012CA2809864A1 Identification and enrichment of cell subpopulations
03/08/2012CA2809863A1 Lipids suitable for liposomal delivery of protein-coding rna
03/08/2012CA2809851A1 Pegylated liposomes for delivery of immunogen-encoding rna
03/08/2012CA2809837A1 Human immunodeficiency virus (hiv)-neutralizing antibodies
03/08/2012CA2809780A1 Influenza virus neutralizing antibody and method for screening same
03/08/2012CA2809678A1 Small liposomes for delivery of immunogen-encoding rna
03/08/2012CA2809677A1 Anti-c-met antibody and methods of use thereof
03/08/2012CA2809568A1 Treatment of myocardial infarction using tgf - beta antagonists
03/08/2012CA2809493A1 Peptide or peptide complex binding to .alpha.2 integrin and methods and uses involving the same
03/08/2012CA2809443A1 Novel antigen binding proteins
03/08/2012CA2809127A1 Newcastle disease virus vectored herpesvirus vaccines
03/08/2012CA2808236A1 Biomarkers and methods of treatment
03/07/2012EP2426150A1 Anti-NKG2A antibodies and uses thereof
03/07/2012EP2426149A1 Anti-cadherin antibody
03/07/2012EP2426148A1 Anti-il-3ra antibody for use in treatment of blood tumor
03/07/2012EP2426146A2 Anti-human IL-21 monoclonal antibodies
03/07/2012EP2426145A1 Engineered anti-IL-23p19 antibodies
03/07/2012EP2426144A1 Engineered anti-IL-23p19 antibodies
03/07/2012EP2426143A2 Method of providing disease-specific binding molecules and targets
03/07/2012EP2426142A2 Modified vaccinia virus strains for use in a diagnostic and therapeutic method
03/07/2012EP2426141A2 Method for preventing or treating M tuberculosis infection
03/07/2012EP2426140A1 Identification of porphyromonas gingivalis virulence polynucleotides in the diagnosis, treatment, and monitoring periodontal diseases
03/07/2012EP2425856A1 Multivalent pneumococcal polysaccharide-protein conjugate composition
03/07/2012EP2425855A1 Multivalent pneumococcal polysaccharide-protein conjugate composition
03/07/2012EP2425854A1 Multivalent pneumococcal polysaccharide-protein conjugate composition
03/07/2012EP2425853A1 Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
03/07/2012EP2425852A1 Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
03/07/2012EP2425851A1 Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
03/07/2012EP2425850A2 Bispecific single chain FV antibody molecules and methods of use thereof
03/07/2012EP2425849A2 Compositions and methods using anti-CS1 antibodies to treat multiple myeloma
03/07/2012EP2425848A2 Influenza immunogen and vaccine
03/07/2012EP2425847A1 Methods of treating cancer using IL-21 and monoclonal antibody therapy
03/07/2012EP2425838A2 Combination therapy for treatment of immune disorders
03/07/2012EP2425010A2 Dual variable domain immunoglobulins and uses thereof
03/07/2012EP2425008A1 Toll-like receptor 3 antagonists
03/07/2012EP2425001A2 Combination anti-hiv vectors, targeting vectors, and methods of use
03/07/2012EP2424990A2 Compositions and methods for enhancing antigen-specific immune responses
03/07/2012EP2424974A1 Mutants of francisella tularensis and uses thereof
03/07/2012EP2424898A1 Gm-csf and interleukin-21 conjugates and uses thereof in the modulation of immune response and treatment of cancer
03/07/2012EP2424897A1 Anti cxcr4 antibodies for the treatment of hiv
03/07/2012EP2424895A1 Compositions and methods for increasing muscle growth
1 ... 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 ... 1823